Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Pharmaceutical Preparations × Clear all

NCT01027676 2013-11-14

Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung